Boxes of Walvax Biotechnology's mRNA COVID-19 vaccine are displayed at a trade fair in Shanghai BEIJING (Reuters) - A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology ...
Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level ...
People who were originally fully vaccinated with the Chinese-made Sinovac COVID-19 vaccine were shown to develop a high degree of immunity after receiving booster doses of either Sinovac, AstraZeneca, ...
BEIJING, June 1 (Reuters) - A COVID-19 vaccine candidate from China's Walvax Biotechnology (300142.SZ), opens new tab using mRNA technology triggered a stronger antibody response against the Omicron ...
BEIJING (Reuters) - Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results